New Leaf Venture Partners, L.L.C. Chimerix Inc Transaction History

New Leaf Venture Partners, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$4.76 - $11.25 $596,904 - $1.41 Million	-125,400 Reduced 9.29%	1,224,600 $11.8 Million
Q4 2018 Feb 13, 2019	BUY	$2.24 - $3.9 $784,000 - $1.37 Million	350,000 Added 35.0%	1,350,000 $3.47 Million
Q3 2018 Nov 13, 2018	BUY	$3.58 - $4.9 $3.58 Million - $4.9 Million	1,000,000 New	1,000,000 $3.89 Million

37M

52.7K

130K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $78.9M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of New Leaf Venture Partners, L.L.C., based on Form 13F filings with the SEC.

Stay updated on New Leaf Venture Partners, L.L.C. with notifications on news.